Pulmonary fibrosis is a scarring of the lung tissue that causes permanent damage to the lungs. As the scar tissue builds up and thickens, it prevents the lungs from transferring oxygen to the blood supply and diminishes the supply of healthy, oxygen-infused blood to the heart, brain, and other organs. The reduced lung function makes it increasingly hard to breathe. While the condition may develop slowly over time, many die within the first three to four years following diagnosis. There is no cure for pulmonary fibrosis, but certain medicines and therapies can help manage the disease, and some people may be candidates for lung transplants.
There are many known contributing factors to pulmonary fibrosis, but determining the exact cause of the scarring can be challenging. For cases in which a cause cannot be linked to the disease, it’s referred to as idiopathic pulmonary fibrosis. Factors that increase the likelihood of developing the disease include a diagnosis of emphysema, a history of smoking, radiation treatments to the chest area, and exposure to harmful pollutants. As a person ages, the risk for building up scar tissue on the lungs also increases, and some cases are thought to have a possible genetic link.
UAB Pulmonary Services is ranked among the best programs of its kind in the nation, and our physicians are consistently listed among the Best Doctors in America for respiratory disease. We serve patients at our main campus and also at our convenient neighborhood clinics in Hoover and Gardendale.
Most UAB Pulmonary Services doctors are triple-board-certified in internal medicine, critical care, and pulmonary medicine. They serve on national boards and specialty organizations, speak at national conferences, publish in scientific and medical journals, and conduct research that is recognized nationally and internationally. Our physicians are continually seeking new ways to treat lung disease and improve the care for patients.
Videos
Find a Provider to Schedule an Appointment
Resources
- The Interstitial Lung Disease Program
- Division of Pulmonary, Allergy and Critical Care Medicine
- Pulmonary Fibrosis Foundation
- Pulmonary Fibrosis
Related Specialties
Clinical Trials
Speak to your physician about your options and browse the link below for more information
Latest News
View All News-
UAB HHT Clinic named Center of Excellence
July 11, 2023
-
Dupilumab lessens disease in COPD patients with type 2 inflammation
June 20, 2023
-
How cadmium-induced inflammation increases the severity and mortality of lung infections
April 19, 2023
-
Nutrition for cystic fibrosis: how UAB is blazing new paths for patients
April 13, 2023
-
COVID-19: Bacterial co-infection is a major risk factor for death, ICU admission and mechanical ventilation
February 28, 2023